Alpha 2.0
Login Register
» Authors » J Jespersen

J Jespersen

Explore the profile of J Jespersen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 247
Citations 1074
Followers 0
Related Specialties
Hematology
Cardiology & Vascular Diseases
General Medicine
Top 10 Co-Authors
J Gram
C Kluft
L Poller
E M Bladbjerg
A Tripodi
P Marckmann
S Munkvad
S O Skouby
J Sidelmann
B Sandstrom
Published In
Thromb Haemost
Ugeskr Laeger
J Thromb Haemost
Thromb Res
Scand J Clin Lab Invest
Affiliations
Soon will be listed here.
Recent Articles
1.
Status and perspectives of biomarker validation for diagnosis, stratification, and treatment
Skov J, Kristiansen K, Jespersen J, Olesen P
Public Health . 2020 Dec; 190:173-175. PMID: 33309006
Objectives: The aim of this study was to discuss the status of and perspective for biomarker validation in view of the challenges imposed on national healthcare systems due to an...
2.
International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain
van den Besselaar A, Chantarangkul V, Angeloni F, Binder N, Byrne M, Dauer R, et al.
J Thromb Haemost . 2017 Oct; 16(1):142-149. PMID: 29065247
Summary: Background The availability of International Standards for thromboplastin is essential for the calibration of routine reagents and hence the calculation of the International Normalized Ratio (INR). Stocks of the...
3.
Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study: comment
Skov J, Jespersen J
J Thromb Haemost . 2016 Jul; 14(11):2311-2312. PMID: 27415817
No abstract available.
4.
Warfarin or dabigatran for treatment of atrial fibrillation
Poller L, Jespersen J, Ibrahim S
J Thromb Haemost . 2014 Apr; 12(7):1193-5. PMID: 24766817
Background: New antithrombotic drugs for prevention and treatment of thromboembolic disorders in AF that are less demanding on local staff and facilities than warfarin should be welcomed if proved successful....
5.
The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate
Ibrahim S, Jespersen J, Poller L
J Thromb Haemost . 2013 Aug; 11(8):1540-6. PMID: 23945031
Introduction: The time in target International Normalized Ratio (INR) range (TIR) is used to assess the control and intensity of oral anticoagulation, but it does not measure variation in the...
6.
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al.
Thromb Haemost . 2013 May; 109(5):769-86. PMID: 23636477
Anticoagulants are a mainstay of cardiovascular therapy, and parenteral anticoagulants have widespread use in cardiology, especially in acute situations. Parenteral anticoagulants include unfractionated heparin, low-molecular-weight heparins, the synthetic pentasaccharides fondaparinux,...
7.
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a rebuttal
Poller L, Jespersen J, Ibrahim S, Pattison A
J Thromb Haemost . 2013 Feb; 11(6):1203-5. PMID: 23398659
No abstract available.
8.
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal
Kluft C, Skouby S, Jespersen J, Burggraaf J
J Thromb Haemost . 2012 Nov; 11(2):394-5. PMID: 23140257
No abstract available.
9.
Artificially depleted plasmas are not necessarily commutable with native patient plasmas for International Sensitivity Index calibration and International Normalized Ratio derivation: a reply
Poller L, Jespersen J, Ibrahim S
J Thromb Haemost . 2012 Aug; 10(10):2211-2. PMID: 22863323
No abstract available.
10.
Coagulometer international sensitivity index (ISI) derivation, a rapid method using the prothrombin time/international normalized ratio (PT/INR) Line: a multicenter study
Poller L, Ibrahim S, Jespersen J, Pattison A
J Thromb Haemost . 2012 Apr; 10(7):1379-84. PMID: 22519939
Background: The original WHO procedure for prothrombin time (PT) standardization has been almost entirely abandoned because of the universal use of PT coagulometers. These often give different international normalized ratio...